Arash Mostaghimi

1 month ago | hcplive.com | Tim Smith |Linda Gold |Arash Mostaghimi |Brett King |Raj Chovatiya

Author(s):,This summary, featuring 4 leading experts, provides an overview of what dermatologists may look forward to during the AAD 2025 Annual Meeting. As the American Academy of Dermatology (AAD) 2025 Annual Meeting is beginning this week, the HCPLive editorial team interviewed 4 leading experts in the field of dermatology to describe the elements of AAD to which they are most looking forward.

Dec 2, 2024 | hcplive.com | Arash Mostaghimi |Amy J. McMichael |Brittany G. Craiglow

OpinionVideoDecember 2, 2024Author(s):, JAK inhibitors provide targeted treatment for alopecia by modulating immune pathways, offering a promising therapeutic option. Patient-specific factors, such as disease severity and comorbidities, should guide the selection of JAK inhibitors. Monitoring for potential side effects, including infections and hematologic abnormalities, is crucial in JAK inhibitor therapy. Collaboration with dermatologists can enhance treatment outcomes in alopecia management.

Dec 2, 2024 | consultantlive.com | Arash Mostaghimi |Amy J. McMichael |Brittany G. Craiglow

Dec 2, 2024 | consultantlive.com | Arash Mostaghimi |Amy J. McMichael |Brittany G. Craiglow

Dec 2, 2024 | hcplive.com | Arash Mostaghimi |Amy J. McMichael |Brittany G. Craiglow

OpinionVideoDecember 2, 2024Author(s):, Healthcare providers are essential in educating patients about alopecia's early signs and treatment options, promoting awareness and understanding. Integrating alopecia discussions into routine check-ups and using educational materials can effectively inform patients about the condition. Emphasizing early diagnosis and intervention can lead to more effective management of alopecia, improving patient outcomes.